Function
Locations
Removes the inositol acyl chain in the ER; required for ER exit of GPI-anchored proteins. Deficiency = GPIBD (intellectual disability/encephalopathy).
After a protein has been GPI-anchored by the transamidase, the anchor's lipid moiety is remodeled so the mature GPI-anchored protein can exit the ER, traffic through the Golgi and partition into membrane microdomains (lipid rafts). Three post-GPI-attachment factors carry out the remodeling. In the endoplasmic reticulum, PGAP1 is a GPI inositol-deacylase that removes the acyl chain from the inositol ring of the anchor (the acyl group added earlier by PIGW); this inositol-deacylation is required for efficient ER-to-Golgi transport of GPI-anchored proteins. In the Golgi, fatty-acid remodeling then exchanges the unsaturated sn-2 chain of the phosphatidylinositol for a saturated one: the GPI-specific phospholipase A2 PGAP3 first removes the sn-2 unsaturated fatty acid, and PGAP2 is required to reacylate the resulting lyso-GPI intermediate with a saturated (stearoyl) chain, generating the mature, raft-associating anchor needed for stable cell-surface expression. Inherited defects cause GPI-deficiency disease: PGAP1 (intellectual disability / encephalopathy), PGAP3 (hyperphosphatasia with mental retardation syndrome 4, HPMRS4) and PGAP2 (HPMRS3).
All recommended fields populated.
✗ none found
No MODULE:gpi_anchor_remodeling deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
3 complete review(s) · 0 with deep research · 0 missing review · 3 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| PGAP1 Q75T13 | ✓ | ✓ | ✗ |
| PGAP2 Q9UHJ9 | ✓ | ✓ | ✗ |
| PGAP3 Q96FM1 | ✓ | ✓ | ✗ |
GPI-anchor post-attachment lipid-remodeling segment, grounded to the human enzymes PGAP1 (UniProtKB:Q75T13, GO:0160215 deacylase activity; ER) and the Golgi fatty-acid-remodeling pair PGAP3 (Q96FM1, GO:0016788 ester-bond hydrolase / GPI-specific phospholipase A2) and PGAP2 (Q9UHJ9; no catalytic MF in GOA — modelled by its GPI anchor remodelling BP role). GO molecular-function/BP/location terms were taken from the completed human gene reviews and verified against the local go.db; the PGAP1 reaction (R-HSA-162729) and parent pathway (R-HSA-162710) were verified against the local reactome cache. Each step uses a PANTHER family selector with the human enzyme as representative. Note the two-compartment organisation: PGAP1 inositol-deacylation is an ER-membrane step required for ER exit, whereas the PGAP3/PGAP2 fatty-acid remodeling (sn-2 unsaturated -> saturated) occurs in the Golgi and confers lipid-raft association / stable surface expression. Upstream is the GPI-transamidase module (PIGK/PIGS/PIGT/PIGU/GPAA1) that attaches the anchor; this remodeling module completes GPI-anchor maturation. This is the FIFTH and final module of the GPI-anchor biosynthesis series (GnT -> core glycan -> EtNP additions -> transamidase -> remodeling). Disorders: PGAP1 GPI-deficiency (intellectual disability/encephalopathy), PGAP3 HPMRS4, PGAP2 HPMRS3.
Removes the inositol acyl chain in the ER; required for ER exit of GPI-anchored proteins. Deficiency = GPIBD (intellectual disability/encephalopathy).
Removes the sn-2 unsaturated fatty acid in the Golgi (fatty-acid remodeling step 1). Deficiency = HPMRS4.
Reacylates the lyso-GPI anchor with a saturated fatty acid (remodeling step 2), producing the mature raft-associating anchor. Deficiency = HPMRS3. (GOA carries no catalytic MF for PGAP2 — its precise catalytic vs accessory role is debated — so it is represented by its GPI-remodelling BP role.)